 |
|
|
|
 |
A Study Comparing Beads with Doxorubicin-Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
[Protocol 07-099]
- Full Title :
- A RANDOMIZED SINGLE BLIND CONTROLLED TRIAL OF BEADS VS. DOXORUBICIN ELUTING BEADS FOR ARTERIAL EMBOLIZATION OF HEPATOCELLULAR CARCINOMA (HCC)
- Purpose :
Embolization is a common treatment for patients with liver cancer who cannot have surgery. It involves blocking the blood vessels that supply blood to a liver tumor. The purpose of this study is to evaluate embolization of these blood vessels with small beads alone ("bead block") versus blocking them with the same bead that contains and releases doxorubicin (an anticancer agent that has been used for many years). Researchers want to determine if adding doxorubicin kills more tumor cells than would be killed by just blocking the blood supplying the tumor.
- Eligibility :
To be eligible for this study, patients must meet several criteria, including but not limited to the following:
- Patients must have a confirmed diagnosis of liver cancer (hepatocellular carcinoma). Patients may not be candidates for surgery or must refuse surgery.
- Patients must be physically well enough that they are fully ambulatory, capable of all self care, and are capable of all but physically strenuous activities. As an example, patients must be well enough that they would be able to carry out office work or light housework.
- Patients must be age 18 or older.
For more information and to inquire about eligibility for this study, please contact Dr. Karen T. Brown at 212-639-5882.
|
|
|
|
|
